34. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc. 2007;138( 6):739-745, 747-760.

35. Zachée P, Vermylen J, Boogaerts MA. Hematologic aspects of end-stage renal failure [review]. Ann Hematol. 1994;69( 1):33- 40.

36. Mitch WE, Klahr S (eds). Handbook of Nutrition and the Kidney, 3rd edition. Philadelphia, PA: Lippincott-Raven Publishers; 1998:87-89.

37. Khan AN, Jabeen F, Macdonald S. Hyperparathyroidism, secondary. WebMD eMedicine, September 8, 2005. Available at: http://www.emedicine.com/radio/topic356.htm. Accessed May 20, 2007.

38.National Kidney Foundation. K/DOQI guidelines 2000: Guidelines for vascular access. 2001. Available at: http://www. kidney.org/professionals/kdoqi/guidelines_updates/doqiupva_ i.html#doqiupva1. Accessed May 28, 2007.

39. United States Department of Health and Human Services Centers for Medicare and Medicaid Services. Fistula first breakthrough. Available at: http://www.cms.hhs.gov/ESRDQua lityImproveInit/ 04_FistulaFirstBreakthrough.asp#TopOfPage. Accessed June 10, 2007.

40. Kumar S. Inflammation and infection: implications for chronic and end-stage kidney disease. 2003. Available at: http://www. medscape.com/viewprogram/2832_pnt. Accessed July 24, 2007.

41. Evans N, Forsyth E. End-stage renal disease in people with type

2 diabetes: Systemic manifestations and exercise implications. Phys Ther. 2004;84( 5):454-463.

42. Suzuki N, Yoshida A, Nakano Y. Quantitative analysis of multi-species oral biofilms by TaqMan Real- Time PCR. 2005. Clin Med Res. 2005; 3( 3):176-185. [EDITOR’S NOTE for online edition: full text article available at: http://www.pubmedcentral.nih. gov/articlerender.fcgi?artid=1237159]

43. Byham-Gray L, Wiesen K. A Clinical Guide to Nutrition Care in Kidney Disease. Chicago, IL: American Dietetic Association; 2004.

44. National Institutes of Health Office of Dietary Supplements. Dietary supplement fact sheet: Calcium. Available at: http://ods. od.nih.gov/factsheets/calcium.asp#h8. Accessed July 24, 2007.

45. Leon JB, Albert JM, Gilchrist G, et al. Improving albumin levels among hemodialysis patients: a community-based randomized controlled trial. Am J Kidney Dis. 2006; 48( 1): 28-36.

46. Whitney E, Rolfes S. Understanding Nutrition, Seventh Edition. St. Paul, MN: West Publishing Company; 1996.

47. McCann L, Kelly MP. Integrating physical findings into advanced practice nutrient assessment. Unpublished. Presented at the National Kidney Foundation 2007 Spring Clinical Meeting, April 13, 2007; Orlando, Florida.

48. Famiglietti MB. National Support Pocket Reference, Second Edition. Tulsa, OK: Specialty Cards; 2000.

49. Saab G, Young DO, Gincherman Y, et al. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Pract. 2007:105( 3):c132-8.

50. Taskapan H, Wei M, Oreopoulos DG. 25(OH) vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Int Urol Nephrol. 2006; 38( 2):323- 329.